In this part of his Pharmaceutical Executive video interview, Bill Grambley, CEO of AllazoHealth, identifies how AI can identify patients at risk of medication non-adherence and intervene early to ...

Peter L. Salgo, MD: In order for the drug to work, patients have to take the treatment, which brings us to patient adherence, right? What is the state of patient adherence in regard to these drugs?

The problem of poor patient adherence has been extensively researched, but the rates of nonadherence have not changed much in the past 3 decades. Healthcare providers play a unique and important role ...

Kathy Oubre and Michael Reff, RPh, MBA, address the lack of treatment adherence among patients with MPNs and how to overcome this with a best-practice approach. Bruce Feinberg, DO: We talked a lot ...

Medication is a staple of modern medicine, with almost 50% of adults in the United States taking at least one prescription medication. Despite this, pharmaceutical companies have not won over public ...

Analysis of a large unsubsidized digital weight-loss service reveals that consistent treatment adherence and active ...

While specialty medications offer hope to the more than 20 million Americans currently taking them for complex health conditions, getting that first prescription filled can cost what these patients ...

("BrightInsight"), a leader in digital health solutions, today shared new data from its collaboration with Sanofi and its partner, Regeneron, highlighting the positive impact of the Patient App on ...

If we’re truly serious about reining in health care costs and improving patient outcomes at the same time, then improving medication adherence is absolutely key. And if we’re serious about improving ...